Men With Breast Cancer Present at Later Stage, Have Worse Prognosis Than Women
At 10 years, the disease-free survival rate was 54.5%, and the overall survival rate was 50.7%.
At 10 years, the disease-free survival rate was 54.5%, and the overall survival rate was 50.7%.
Induction chemotherapy was associated with improvements in disease-free, failure-free, relapse-free, and progression-free survival.
Obinutuzumab plus chemotherapy improved progression-free survival and time to next treatment.
Researchers identified demographic and socioeconomic factors associated with differences in staging of non-small cell lung cancer at initial presentation.
The expanded approval was based on data from the phase 3 TRANSFORM and phase 2 PILOT studies.
The arsenic level in drinking water was negatively associated with incidences of lymphoma and leukemia in men and women.
A large cross-sectional study offered a survey of long COVID symptoms in children who have been infected with SARS-CoV-2.
Having a high-deductible health plan was associated with a nearly 5-month delay in the diagnosis of metastatic cancer.
The pooled incidence of chemoradiation-induced grade 3-5 pneumonitis was 3.62% in randomized trials, 5.98% in observational studies, and 7.85% in observational studies of platinum doublet chemotherapy.
Patients who received denosumab had a significant improvement in disease-free survival and bone metastasis-free survival.